Andrew J. Einhorn
CIK 1560685 · Chief Financial Officer · last filed 2025-12-29
Andrew J. Einhorn is a Chief Financial Officer who has filed 11 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for PTHS, was dated Dec 29, 2025. Across all open-market trades the lifetime net is +$495.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $6.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.55M
4
11
$495.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTHS | Director | 12,000 | $27.50 | $330.0K | $0 | 1 | 2025-12-29 |
| RVL Pharmaceuticals plc (RVLP) Delisted | Chief Financial Officer | 164,325 | $0.03 | $4.6K | $0 | 1 | 2022-01-26 |
| RVL Pharmaceuticals plc (OSMT) Delisted | Chief Financial Officer | 173,932 | $1.11 | $193.1K | $0 | 6 | 2021-11-08 |
| EDGE | Chief Financial Officer | 126,815 | $49.07 | $6.22M | $495.0K | 3 | 2017-03-13 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-29 | PTHS | Grant (A) | +12,000 | $0 | EDGAR |
| 2022-01-26 | RVL Pharmaceuticals plc (RVLP) Delisted | Tax (F) | −9,607 | -$10.9K | EDGAR |
| 2021-11-08 | RVL Pharmaceuticals plc (OSMT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-20 | RVL Pharmaceuticals plc (OSMT) Delisted | Tax (F) | −6,467 | -$20.2K | EDGAR |
| 2021-01-26 | RVL Pharmaceuticals plc (OSMT) Delisted | Tax (F) | −9,668 | -$43.1K | EDGAR |
| 2020-05-20 | RVL Pharmaceuticals plc (OSMT) Delisted | Grant (A) | +71,550 | $0 | EDGAR |
| 2020-01-30 | RVL Pharmaceuticals plc (OSMT) Delisted | Tax (F) | −9,184 | -$64.3K | EDGAR |
| 2019-01-28 | RVL Pharmaceuticals plc (OSMT) Delisted | Grant (A) | +104,849 | $0 | EDGAR |
| 2017-03-13 | EDGE | Exer (X) | +1,567 | $3.7K | EDGAR |
| 2016-02-18 | EDGE | Grant (A) | — | $0 | EDGAR |